BG98124A - Active pyrrole-(2,3-)pyridine derivatives - Google Patents

Active pyrrole-(2,3-)pyridine derivatives

Info

Publication number
BG98124A
BG98124A BG98124A BG9812493A BG98124A BG 98124 A BG98124 A BG 98124A BG 98124 A BG98124 A BG 98124A BG 9812493 A BG9812493 A BG 9812493A BG 98124 A BG98124 A BG 98124A
Authority
BG
Bulgaria
Prior art keywords
pyridine derivatives
active pyrrole
active
pyrrole
pyridine
Prior art date
Application number
BG98124A
Other languages
Bulgarian (bg)
English (en)
Inventor
Carin Briving
Marie Elebring
Stig Carlsson
Robert Carter
Thomas Kuehler
Peter Nordberg
Ingemar Starke
Arne Svensson
Original Assignee
Aktiebolaget Astra
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aktiebolaget Astra filed Critical Aktiebolaget Astra
Publication of BG98124A publication Critical patent/BG98124A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BG98124A 1991-03-27 1993-09-23 Active pyrrole-(2,3-)pyridine derivatives BG98124A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9100920A SE9100920D0 (sv) 1991-03-27 1991-03-27 New active compounds
PCT/SE1992/000190 WO1992017477A1 (en) 1991-03-27 1992-03-25 New active compounds

Publications (1)

Publication Number Publication Date
BG98124A true BG98124A (en) 1994-11-15

Family

ID=20382295

Family Applications (1)

Application Number Title Priority Date Filing Date
BG98124A BG98124A (en) 1991-03-27 1993-09-23 Active pyrrole-(2,3-)pyridine derivatives

Country Status (30)

Country Link
US (1) US5439917A (es)
EP (2) EP0580616A1 (es)
JP (1) JP3122792B2 (es)
CN (1) CN1067892A (es)
AP (1) AP309A (es)
AT (1) ATE175672T1 (es)
AU (1) AU655634B2 (es)
BG (1) BG98124A (es)
CA (1) CA2106880A1 (es)
DE (1) DE69228142T2 (es)
DK (1) DK0509974T3 (es)
ES (1) ES2129039T3 (es)
FI (1) FI934203A (es)
GR (1) GR3029834T3 (es)
HU (1) HUT65948A (es)
IE (1) IE920915A1 (es)
IL (1) IL101347A0 (es)
IS (1) IS3827A (es)
JO (1) JO1704B1 (es)
MA (1) MA22477A1 (es)
MX (1) MX9201324A (es)
NO (1) NO933425L (es)
NZ (1) NZ241943A (es)
SE (1) SE9100920D0 (es)
SK (1) SK103093A3 (es)
TN (1) TNSN92026A1 (es)
TW (1) TW198032B (es)
WO (1) WO1992017477A1 (es)
YU (1) YU30292A (es)
ZA (1) ZA921823B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9100920D0 (sv) * 1991-03-27 1991-03-27 Astra Ab New active compounds
US6852739B1 (en) * 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
CA2699568C (en) * 1999-12-24 2013-03-12 Aventis Pharma Limited Azaindoles
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
GB0115109D0 (en) 2001-06-21 2001-08-15 Aventis Pharma Ltd Chemical compounds
MY140561A (en) * 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
EP1490364B1 (en) 2002-03-28 2007-09-26 Eisai R&D Management Co., Ltd. 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders
CA2493618A1 (en) * 2002-08-01 2004-02-12 Nitromed, Inc. Nitrosated proton pump inhibitors, compositions and methods of use
GB0305142D0 (en) * 2003-03-06 2003-04-09 Eisai London Res Lab Ltd Synthesis
PL1606261T3 (pl) 2003-03-10 2010-04-30 Astrazeneca Ab Nowy sposób przygotowania roflumilastu
US6981980B2 (en) 2003-03-19 2006-01-03 Phagia Technology Self-inflating intragastric volume-occupying device
WO2004101565A2 (en) * 2003-05-16 2004-11-25 Eisai Co., Ltd. Jnk inhibitors
GB0405055D0 (en) * 2004-03-05 2004-04-07 Eisai London Res Lab Ltd JNK inhibitors
ES2421916T3 (es) * 2005-03-16 2013-09-06 Nycomed Gmbh Forma farmacéutica de sabor enmascarado que contiene roflumilast
GB0516156D0 (en) * 2005-08-05 2005-09-14 Eisai London Res Lab Ltd JNK inhibitors
CL2007002617A1 (es) 2006-09-11 2008-05-16 Sanofi Aventis Compuestos derivados de pirrolo[2,3-b]pirazin-6-ilo; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar inflamacion de las articulaciones, artritis reumatoide, tumores, linfoma de las celulas del manto.
EP2486910A3 (en) 2006-10-27 2012-08-22 The Curators Of The University Of Missouri Multi-chambered apparatus comprising a dispenser head
EP2252274A4 (en) 2008-02-20 2011-05-11 Univ Missouri COMPOSITION COMPRISING A COMBINATION OF OMEPRAZOLE AND LANSOPRAZOLE, AND A BUFFER AGENT, AND METHODS OF USING THE SAME
KR102348222B1 (ko) * 2020-05-15 2022-01-10 대한민국 아동지킴이 과속방지시설

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9100920D0 (sv) * 1991-03-27 1991-03-27 Astra Ab New active compounds

Also Published As

Publication number Publication date
ATE175672T1 (de) 1999-01-15
DK0509974T3 (da) 1999-08-30
EP0580616A1 (en) 1994-02-02
NO933425L (no) 1993-10-25
NZ241943A (en) 1993-12-23
IL101347A0 (en) 1992-11-15
MX9201324A (es) 1992-10-01
CA2106880A1 (en) 1992-09-28
CN1067892A (zh) 1993-01-13
US5439917A (en) 1995-08-08
SE9100920D0 (sv) 1991-03-27
ZA921823B (en) 1992-11-25
HU9302741D0 (en) 1993-12-28
AP9200369A0 (en) 1992-04-30
WO1992017477A1 (en) 1992-10-15
ES2129039T3 (es) 1999-06-01
AU655634B2 (en) 1995-01-05
AU1426092A (en) 1992-11-02
IS3827A (is) 1992-09-28
FI934203A0 (fi) 1993-09-24
IE920915A1 (en) 1992-10-07
SK103093A3 (en) 1994-08-10
DE69228142D1 (de) 1999-02-25
HUT65948A (en) 1994-08-29
JPH06506448A (ja) 1994-07-21
EP0509974A1 (en) 1992-10-21
FI934203A (fi) 1993-09-24
NO933425D0 (no) 1993-09-24
EP0509974B1 (en) 1999-01-13
AP309A (en) 1994-01-13
YU30292A (sh) 1995-01-31
TNSN92026A1 (fr) 1993-06-08
JP3122792B2 (ja) 2001-01-09
GR3029834T3 (en) 1999-06-30
TW198032B (es) 1993-01-11
DE69228142T2 (de) 1999-07-22
JO1704B1 (en) 1992-12-15
MA22477A1 (fr) 1992-10-01

Similar Documents

Publication Publication Date Title
BG98124A (en) Active pyrrole-(2,3-)pyridine derivatives
ATE126215T1 (de) Anti-entzündende 4-aminophenol-derivate.
IE781878L (en) Imidazole derivatives
NO920494D0 (no) Terapeutiske, heterosykliske forbindelser
LU90944I2 (fr) Dérivés pipérazinyl-héterocycliques
CA2130754A1 (en) Amine derivatives of oxo- and hydroxy-substituted hydrocarbons
IL98110A0 (en) N-(3-fluoro-2-phosphonylmethoxypropyl)derivatives of purine and pyrimidine heterocyclic bases,their preparation and use
FR2669029B1 (fr) Nouveaux derives de la n-benzoyl proline, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
MY132057A (en) Quinoxalinones, a process for their preparation and their use
GR1000156B (el) ΜΕΘΟΔΟΣ ΠΑΡΑΣΚΕΥΗΣ ΝΕΩΝ ΠΑΡΑΓΩΓΩΝ ΤΡΙΚΥΚΛΙΚΩΝ ΑΜΙΝΩΝ ΤΗΣ ΤΕΤΡΑΥΔΡΟ-5,6,7,8ΝΑΦΘΟ[2,3b] ΔΙΥΔΡΟ-2,3 ΦΟΥΡΑΝΗΣ & ΤΗΣ ΤΕΤΡΑΥΔΡΟ-6,7,8,9 5Η-ΒΕΝΖΟΚΥΚΛΟΕΠΤΑ[2,3Β] ΔΙΥΔΡΟ-2,3 ΦΟΥΡΑΝΗΣ.
CA2144344A1 (en) Cyclic benzylamino, benzylamido and benzylimido derivatives as antipsychotic agents
TR199701298T1 (xx) Tetralinler.
FI842112A0 (fi) Foerfarande foer framstaellning av- karbolin-3-karboxylsyraderivat.
FI934647A (fi) Alkoximetylsubstituerade pyridonbifenyler
NO174963C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 8-fluorantracyklinglucosider
MY131110A (en) Ergoline derivatives
GR1001405B (el) Ενώσεις 2-πιπεραζινόνης και η παραγωγή και η χρησιμοποίηση αυτών.
NO20002407L (no) Pyrrolo[3,2-b]pyridin-fremgangsmÕter og mellomprodukter
SU1783778A1 (ru) Производные 4-(1-окси-1-аминокарбонил-2,2,2-трифторэтил)-n-этиланилинов, обладающие антидотной активностью к хлорсульфурону
MY102589A (en) Pyridine derivatives
NO930016D0 (no) Derivater av hypofysens baklapphormoner
SE9000857D0 (sv) Novel use of theraeutically active compound